Home >> Service Industries >>

Global Cell Based Assays Detailed Analysis Report 2017-2022

Published: Oct-2017 | Format: PDF | Detailed Analysis Research | Number of pages: 129 | Code: MRS - 180211

This report mainly introduces volume and value market share by players, by regions, by product type, by consumers and also their price change details. As a Detailed Analysis report, it covers all details inside analysis and opinion in Cell Based Assays industry.

This report splits Cell Based Assays market By product type, By Usage Type, which covers the history data information from 2012 to 2016 and forecast from 2017 to 2022.

This report focuses Global market, it covers details as following:

Major Companies

  • Merck KGaA (Germany)
  • Becton (U.S.)
  • PerkinElmer Inc. (U.S.)
  • Promega Corporation (U.S.)
  • Danaher Corporation (U.S.)
  • GE Healthcare (U.K)
  • Thermo Fisher Scientific Inc. (U.S.)
  • Cell Signaling Technology, Inc. (U.S.)
  • BioTek Instruments, Inc. (U.S.)
  • Lonza Group (U.S.)
  • ProQinase GmbH (Germany)
  • Charles River Laboratories, Inc (U.S.)
  • Cisbio Bioassays (France)
  • Miltenyi Biotec (Germany)
  • Cell Biolabs, Inc. (U.S.)
  • DiscoverX Corporation (U.S.)
  • Marin Biologic Laboratories (U.S.)
  • Biospherix, Ltd (U.S.)
  • Essen BioScience Inc. (U.S.)
  • Cell Biologics Inc. (U.S.)
  • BioAgilytix Labs. (U.S.)
  • Enzo Life Sciences, Inc. (Switzerland)
  • Aurelia Bioscience Ltd. (U.K. )
  • Selexis SA (U.S.)
  • QGel SA (Switzerland)

Main Regions

  • North America
  • United States
  • Canada
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Russia
  • Netherland
  • Others
  • Asia & Pacific
  • China
  • Japan
  • India
  • Korea
  • Australia
  • Southeast Asia
  • Indonesia
  • Thailand
  • Philippines
  • Vietnam
  • Singapore
  • Malaysia
  • Others
  • Africa & Middle East
  • South Africa
  • Egypt
  • Turkey
  • Saudi Arabia
  • Iran
  • Others

Main Product Type

  • Cell Based Assays Market, by product type
  • Consumables
  • Instruments
  • Services
  • Software
  • Cell Based Assays Market, by Usage Type
  • Drug discovery
  • Basic Research
  • ADME Studies
  • Predictive Toxicology
  • Other Applications

Main Applications

  • Pharmaceutical & Biotechnology Companies
  • Academic & Government Institutions
  • Contract Research Organizations
  • Other End Users

Table of Contents

Global Cell Based Assays Detailed Analysis Report 2017-2022
Chapter One Cell Based Assays Market Overview
    1.1 Global Cell Based Assays Market Sales Volume Revenue and Price 2012-2022
    1.2 Cell Based Assays, By product type 2012-2022
        1.2.1 Global Cell Based Assays Sales Market Share by product type 2012-2022
        1.2.2 Global Cell Based Assays Revenue Market Share by product type 2012-2022
        1.2.3 Global Cell Based Assays Price by product type 2012-2022
        1.2.4 Consumables
        1.2.5 Instruments
        1.2.6 Services
        1.2.7 Software
    1.3 Cell Based Assays, by Usage Type 2012-2022
        1.3.1 Global Cell Based Assays Sales Market Share by Usage Type 2012-2022
        1.3.2 Global Cell Based Assays Revenue Market Share by Usage Type 2012-2022
        1.3.3 Global Cell Based Assays Price by Usage Type 2012-2022
        1.3.4 Drug discovery
        1.3.5 Basic Research
        1.3.6 ADME Studies
        1.3.7 Predictive Toxicology
        1.3.8 Other Applications

Chapter Two Cell Based Assays by Regions 2012-2017
    2.1 Global Cell Based Assays Sales Market Share by Regions 2012-2017
    2.2 Global Cell Based Assays Revenue Market Share by Regions 2012-2017
    2.3 Global Cell Based Assays Price by Regions 2012-2017
    2.4 North America
        2.4.1 United States
        2.4.2 Canada
    2.5 Latin America
        2.5.1 Mexico
        2.5.2 Brazil
        2.5.3 Argentina
        2.5.4 Others in Latin America
    2.6 Europe
        2.6.1 Germany
        2.6.2 United Kingdom
        2.6.3 France
        2.6.4 Italy
        2.6.5 Spain
        2.6.6 Russia
        2.6.7 Netherland
        2.6.8 Others in Europe
    2.7 Asia & Pacific
        2.7.1 China
        2.7.2 Japan
        2.7.3 India
        2.7.4 Korea
        2.7.5 Australia
        2.7.6 Southeast Asia
            2.7.6.1 Indonesia
            2.7.6.2 Thailand
            2.7.6.3 Philippines
            2.7.6.4 Vietnam
            2.7.6.5 Singapore
            2.7.6.6 Malaysia
            2.7.6.7 Others in Southeast Asia
    2.8 Africa & Middle East
        2.8.1 South Africa
        2.8.2 Egypt
        2.8.3 Turkey
        2.8.4 Saudi Arabia
        2.8.5 Iran
        2.8.6 Others in Africa & Middle East

Chapter Three Cell Based Assays by Players 2012-2017
    3.1 Global Cell Based Assays Sales Volume Market Share by Players 2012-2017
    3.2 Global Cell Based Assays Revenue Share by Players 2012-2017
    3.3 Global Top Players Cell Based Assays Key Product Model and Market Performance
    3.4 Global Top Players Cell Based Assays Key Target Consumers and Market Performance

Chapter Four Cell Based Assays by Consumer 2012-2017
    4.1 Global Cell Based Assays Sales Market Share by Consumer 2012-2017
    4.2 Pharmaceutical & Biotechnology Companies
    4.3 Academic & Government Institutions
    4.4 Contract Research Organizations
    4.5 Other End Users
    4.6 Consuming Habit and Preference

Chapter Five Global Top Players Profile
    5.1 Merck KGaA (Germany)
        5.1.1 Merck KGaA (Germany) Company Details and Competitors
        5.1.2 Merck KGaA (Germany) Key Cell Based Assays Models and Performance
        5.1.3 Merck KGaA (Germany) Cell Based Assays Business SWOT Analysis and Forecast
        5.1.4 Merck KGaA (Germany) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.2 Becton (U.S.)
        5.2.1 Becton (U.S.) Company Details and Competitors
        5.2.2 Becton (U.S.) Key Cell Based Assays Models and Performance
        5.2.3 Becton (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.2.4 Becton (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.3 PerkinElmer Inc. (U.S.)
        5.3.1 PerkinElmer Inc. (U.S.) Company Details and Competitors
        5.3.2 PerkinElmer Inc. (U.S.) Key Cell Based Assays Models and Performance
        5.3.3 PerkinElmer Inc. (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.3.4 PerkinElmer Inc. (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.4 Promega Corporation (U.S.)
        5.4.1 Promega Corporation (U.S.) Company Details and Competitors
        5.4.2 Promega Corporation (U.S.) Key Cell Based Assays Models and Performance
        5.4.3 Promega Corporation (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.4.4 Promega Corporation (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.5 Danaher Corporation (U.S.)
        5.5.1 Danaher Corporation (U.S.) Company Details and Competitors
        5.5.2 Danaher Corporation (U.S.) Key Cell Based Assays Models and Performance
        5.5.3 Danaher Corporation (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.5.4 Danaher Corporation (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.6 GE Healthcare (U.K)
        5.6.1 GE Healthcare (U.K) Company Details and Competitors
        5.6.2 GE Healthcare (U.K) Key Cell Based Assays Models and Performance
        5.6.3 GE Healthcare (U.K) Cell Based Assays Business SWOT Analysis and Forecast
        5.6.4 GE Healthcare (U.K) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.7 Thermo Fisher Scientific Inc. (U.S.)
        5.7.1 Thermo Fisher Scientific Inc. (U.S.) Company Details and Competitors
        5.7.2 Thermo Fisher Scientific Inc. (U.S.) Key Cell Based Assays Models and Performance
        5.7.3 Thermo Fisher Scientific Inc. (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.7.4 Thermo Fisher Scientific Inc. (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.8 Cell Signaling Technology, Inc. (U.S.)
        5.8.1 Cell Signaling Technology, Inc. (U.S.) Company Details and Competitors
        5.8.2 Cell Signaling Technology, Inc. (U.S.) Key Cell Based Assays Models and Performance
        5.8.3 Cell Signaling Technology, Inc. (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.8.4 Cell Signaling Technology, Inc. (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.9 BioTek Instruments, Inc. (U.S.)
        5.9.1 BioTek Instruments, Inc. (U.S.) Company Details and Competitors
        5.9.2 BioTek Instruments, Inc. (U.S.) Key Cell Based Assays Models and Performance
        5.9.3 BioTek Instruments, Inc. (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.9.4 BioTek Instruments, Inc. (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.10 Lonza Group (U.S.)
        5.10.1 Lonza Group (U.S.) Company Details and Competitors
        5.10.2 Lonza Group (U.S.) Key Cell Based Assays Models and Performance
        5.10.3 Lonza Group (U.S.) Cell Based Assays Business SWOT Analysis and Forecast
        5.10.4 Lonza Group (U.S.) Cell Based Assays Sales Volume Revenue Price Cost and Gross Margin
    5.11 ProQinase GmbH (Germany)
    5.12 Charles River Laboratories, Inc (U.S.)
    5.13 Cisbio Bioassays (France)
    5.14 Miltenyi Biotec (Germany)
    5.15 Cell Biolabs, Inc. (U.S.)
    5.16 DiscoverX Corporation (U.S.)
    5.17 Marin Biologic Laboratories (U.S.)
    5.18 Biospherix, Ltd (U.S.)
    5.19 Essen BioScience Inc. (U.S.)
    5.20 Cell Biologics Inc. (U.S.)
    5.21 BioAgilytix Labs. (U.S.)
    5.22 Enzo Life Sciences, Inc. (Switzerland)
    5.23 Aurelia Bioscience Ltd. (U.K. )
    5.24 Selexis SA (U.S.)
    5.25 QGel SA (Switzerland)

Chapter Six Industry Chain and Supply Chain
    6.1 Cell Based Assays Industry Chain Structure
        6.1.1 R&D
        6.1.2 Raw Materials (Components)
        6.1.3 Manufacturing Plants
        6.1.4 Regional Trading (Import Export and Local Sales)
        6.1.5 Online Sales Channel
        6.1.6 Offline Channel
        6.1.7 End Users
    6.2 Cell Based Assays Manufacturing
        6.2.1 Key Components
        6.2.2 Assembly Manufacturing
    6.3 Consumer Preference
    6.4 Behavioral Habits
    6.5 Marketing Environment

Chapter Seven Global Cell Based Assays Market Size (Sales and Revenue) Forecast (2017-2022)
    7.1 Global Cell Based Assays Sales (Million Units), Revenue (Million USD) Forecast (2017-2022)
    7.2 Global Cell Based Assays Sales (Million Units) Forecast by Regions (2017-2022)
    7.3 Global Cell Based Assays Sales (Million Units) Forecast by Application (2017-2022)
    7.4 Global Cell Based Assays Sales (Million Units) Forecast by product type (2017-2022)
    7.5 Global Cell Based Assays Sales (Million Units) Forecast by Usage Type (2017-2022)

Chapter Eight Development Trend and Research Conclusion
    8.1 Development Trend
    8.2 Research Conclusion

Chapter Nine Methodology and Data Source
    9.1 Methodology/Research Approach
        9.1.1 Research Programs/Design
        9.1.2 Market Size Estimation
        9.1.3 Market Breakdown and Data Triangulation
    9.2 Data Source
        9.2.1 Secondary Sources
        9.2.2 Primary Sources
    9.3 Disclaimer



                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode

COVID-19 Pandemic Impacts

Our Analysts and Consultants are working ceaselessly to congregate, identify, analyze, and portray the Actual Impacts of COVID-19 Global Pandemic in each of our published as well as ongoing research reports to Redefine and Revise Current and Future Market Trends, Growth Rates, And Market Size Projections across the Globe as well as in different Regions and individual Countries.

Single User | $(USD)3250 View Pricing